Publications by authors named "Gavin Marx"

Claim this Profile
E
Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points.
Neal D Shore, Ugo De Giorgi, Ronald F Tutrone, James L Bailen, Erik P M Roos, Gavin Marx

J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions - a retrospective cohort review.
Nicholas Della Marta, Alexander Yuile, Claire Mok, Joe Wei, Meredith Oatley, Gavin M Marx

Cancer Treat Res Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304).
Ciara Conduit, Andrisha-Jade Inderjeeth, Raymond Allen, Andrew J Martin, Wendy Parulekar, Gavin M Marx

Future Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial.
Peter Grimison, Antony Mersiades, Adrienne Kirby, Annette Tognela, Ian Olver, Gavin Marx

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has the COVID-19 pandemic resulted in more advanced breast cancer? A hospital-based retrospective study.
Gemma Howdle, Adam Stephanou, Jordan Barrett, Suzannah Roushdy, Nicholas Ngui, Gavin Marx

ANZ J Surg· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance.
Malinda Itchins, Shirley Liang, Chris Brown, Tristan Barnes, Gavin Marx

JTO Clin Res Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia.
Gavin Marx, Simon Chowdhury, Laurence Krieger, Elizabeth Hovey, Jeremy Shapiro

Asia Pac J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy.
Tiffany Li, Hannah C Timmins, Fawaz M Mahfouz, Terry Trinh, David Mizrahi, Gavin Marx

JAMA Netw Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.
Kate L Mahon, Sarah Im Sutherland, Hui Ming Lin, Martin R Stockler, Howard Gurney, Gavin Marx

Prostate· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological and clinical outcomes following neoadjuvant dual HER2 therapy for early-stage breast cancer: An Australian institutional real-world experience.
Sathya Narayanan, Nicholas K Ngui, Ben Kinchington, Joseph Do Woong Choi, Thomas Michael D Hughes, Gavin Marx

Cancer Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of endoscopic ultrasound-guided gastro-enterostomy for gastric outlet obstruction in a two-centre Australian Cohort (with video).
Martin Harb, Arvind Kamath, Gavin Marx, Saurabh Gupta

Asia Pac J Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity.
Fawaz Mayez Mahfouz, Tiffany Li, Hannah C Timmins, Lisa G Horvath, Michelle Harrison, Gavin Marx

J Natl Compr Canc Netw· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells.
Vinod Ganju, Gavin Marx, Scott Pattison, Nancy B Amaro-Mugridge, Jing-Ting Zhao

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes.
Fawaz Mayez Mahfouz, Tiffany Li, Masarra Joda, Michelle Harrison, Lisa G Horvath, Gavin Marx

Support Care Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial.
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Leanna Cheung, Gavin Marx

Lancet Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy.
David Mizrahi, David Goldstein, Terry Trinh, Tiffany Li, Hannah C Timmins, Gavin M Marx

Asia Pac J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
Arlene Chan, Manuel Ruiz-Borrego, Gavin Marx, A Jo Chien, Hope S Rugo

Breast· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Sheau Wen Lok, Richard De Boer, Sally Baron-Hay, Peter Button, Bianca Devitt, Gavin Marx

Int J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of the Oncotype DX Test for Breast Cancer Patients in an Australian Multidisciplinary Setting.
Joseph Do Woong Choi, T Michael D Hughes, Gavin Marx, John Boyages, Josie Rutovitz

Breast J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
Martin R Stockler, Andrew J Martin, Ian D Davis, Haryana M Dhillon, Stephen D Begbie, Gavin M Marx

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.
Blossom Mak, Hui-Ming Lin, Edmond M Kwan, Heidi Fettke, Ben Tran, Gavin Marx

BMC Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer.
Hui-Ming Lin, Nicole Yeung, Jordan F Hastings, David R Croucher, Kevin Huynh, Gavin Marx

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.
Hui-Ming Lin, Blossom Mak, Nicole Yeung, Kevin Huynh, Thomas G Meikle, Gavin Marx

EBioMedicine· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy.
Christopher J Sweeney, Andrew J Martin, Martin R Stockler, Stephen Begbie, Kim N Chi, Gavin M Marx

Eur Urol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].
Stephen John Clarke, Matthew Burge, Kynan Feeney, Peter Gibbs, Kristian Jones, Gavin Marx

PLoS One· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis